Mark Ibberson

16PUBLICATIONS

153CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPeripheral nervous system

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 03, 2026

Epigenetic landscapes in human pancreatic islets reveal distinct drivers for adaptation to age and type 2 diabetes.

|Feb 07, 2026

Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial.

Wenjun Ju, Viji Nair, Priya Vart

|Oct 10, 2025

Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches.

Mara Suleiman, Toshiaki Sawatani, Marta Tesi

|Nov 20, 2024

Profiling of insulin-resistant kidney models and human biopsies reveals common and cell-type-specific mechanisms underpinning Diabetic Kidney Disease.

Abigail C Lay, Van Du T Tran, Viji Nair

|Jul 24, 2024

Examining immune-inflammatory mechanisms of probiotic supplementation in depression: secondary findings from a randomized clinical trial.

Lukas Sempach, Jessica P K Doll, Verena Limbach

|Jul 22, 2024

Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

Joseph Mellor, Dmitry Kuznetsov, Simon Heller

Pageof 3

Frequent Collaborators

Florence Mehl

Rory J McCrimmon

Bernard Thorens

Frédéric Burdet

Dmitry Kuznetsov

Phillippe Froguel

Mathias J Gerl

Roderick C Slieker

Anna L Gloyn

Alvin C Powers

Frequent Collaborators

Florence Mehl

Rory J McCrimmon

Bernard Thorens

Frédéric Burdet